Logo

Concord Biotech Share Price

Concord Biotech (INR)2129.354.2   (0.2%)

Exchange ScripsBSE543960NSECONCORDBIOISININE338H01029

Stock Performance
Fundamentals
Technicals
Shareholding Patterns
Financials
Similar Stocks

Trendline of performance -

Concord Biotech Performance

Market performance
Open price2150
High2162.95
Volumes55257
Prev Close2129.35
Low2096.05
Closing date2024-12-20
Historical performance
1 Year High2664.00
3 Year High2664.00
5 Year High2664.00
1 Year Low1322.30
3 Year Low900.05
5 Year Low900.05

Concord Biotech Fundamentals

Company Valuation
Market Cap
Market Cap (₹Cr)
22231
Face Value
Face Value (₹)
1
P/E Ratio
P/E Ratio
72.3
Dividend Yield
Dividend Yield
0.41 %

Concord Biotech Investment Returns

1 Year
57.8%
3 Years
N/A
5 Years
N/A
10 Years
N/A

Concord Biotech Technicals

IndicatorsValueSignal
5-DMA2118.1Bullish
10-DMA2123.38Bullish
20-DMA2126.51Bullish
50-DMA1981.36Bullish
100-DMA1904.61Bullish
200-DMA1721.91Bullish

Shareholding Pattern

FieldSep-2024Jun-2024Mar-2024Dec-2023Sep-2023
Promoters66666
Foreign Investors---------------
Domestic Investors66666
Public Investors84292807318329087480100921
Government---------------

Concord Biotech Financials

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Other Income338353234138
Operating Profit4660383929733417
Interest32986110
Depreciation536540500275
Profit Before Tax4126322023753127
Consolidated Net Profit3081240117492348
Adjusted EPS29231722

Balance Sheet

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Share Capital1051059595
Total Reserves1516212795109379899
Minority Interest------------
Total Non-Current Liabilities319321544774
Total Liabilities17007151401501913127
Capital Work in Progress21151727742179
Total Assets17007151401501913127

Cash Flow

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Cash Flow from Operating Activities2655246020751668
Cash Flow from Investing Activities-1546-1580-1118-1952
Cash Flow from Financing Activitie-992-852-1002311
Net Cash Inflow / Outflow11628-4527
0%
Negative
Neutral
Positive
  • The stock has a PE ratio of 72.3.
  • 3Y Stock Price CAGR of the stock is 125.9.
  • The stock has a beta of 0.6.
  • In the last financial year, the company had an EBITDA of ₹4660 Million.
  • The company generated revenue of ₹10169 Million in the previous financial year.

Concord Biotech

2129.354.2   (0.2%)

Investment Amount: ₹ 136120
Current Value: ₹ 212935
Performance: 56.4%
P/L: ₹ 76815
Top Gainers
SymbolChange%
KOTHARIPRO205.06(20%)
LAGNAM132.13(18%)
GICRE501(13%)
HISARMETAL217.94(11%)
DIAMONDYD1081.55(11%)
Top Losers
SymbolChange%
UNIINFO37.61(-13%)
BALAJITELE79.8(-10%)
SIEMENS6868.9(-10%)
MOBIKWIK487.95(-10%)
TORNTPOWER1479.2(-9%)
BAJAJHCARE533.9(-9%)
SARLAPOLY116.77(-9%)
SURYALAXMI87.14(-9%)
Similar stocks

Zota Health Care

41.3

783.7

November 20 - December 20

Ind-Swift

37.2

29.04

November 20 - December 20

Bajaj Healthcare

35.8

533.9

November 20 - December 20

Bliss GVS Pharma

33.6

161.15

November 20 - December 20

Lincoln Pharma

30.3

812.1

November 20 - December 20

Vimta Labs

29.6

961.9

November 20 - December 20

Wanbury

26.7

284.49

November 20 - December 20

Dishman Carbogen Amc

25.4

275.87

November 20 - December 20

Announcing Stock of the Month!

Stock of the Month
Stock of the Month